XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At-the-Market Program
March 2020 Offering
February 2021 Offering
Common Stock $0.001 par value
Common Stock $0.001 par value
At-the-Market Program
Common Stock $0.001 par value
March 2020 Offering
Common Stock $0.001 par value
February 2021 Offering
Additional Paid-In Capital
Additional Paid-In Capital
At-the-Market Program
Additional Paid-In Capital
March 2020 Offering
Additional Paid-In Capital
February 2021 Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2019 $ 5,835       $ 1       $ 111,509       $ (902) $ (104,773)
Beginning Balance, Shares at Dec. 31, 2019         877,672                  
Proceeds from the issuance of common stock   $ 5,043 $ 1,348             $ 5,043 $ 1,348      
Proceeds from the issuance of common stock, Shares           232,526 178,776              
Warrant issued     $ 842               $ 842      
Share issuance costs (506)               (506)          
Stock-based compensation 1,571               1,571          
Foreign currency translation adjustments 381                       381  
Net loss (8,118)                         (8,118)
Ending Balance at Jun. 30, 2020 6,396       $ 1       119,807       (521) (112,891)
Ending Balance, Shares at Jun. 30, 2020         1,288,974                  
Beginning Balance at Mar. 31, 2020 5,209       $ 1       115,004       (266) (109,530)
Beginning Balance, Shares at Mar. 31, 2020         1,086,902                  
Proceeds from the issuance of common stock   $ 4,240               $ 4,240        
Proceeds from the issuance of common stock, Shares           202,072                
Share issuance costs (166)               (166)          
Stock-based compensation 729               729          
Foreign currency translation adjustments (255)                       (255)  
Net loss (3,361)                         (3,361)
Ending Balance at Jun. 30, 2020 6,396       $ 1       119,807       (521) (112,891)
Ending Balance, Shares at Jun. 30, 2020         1,288,974                  
Beginning Balance at Dec. 31, 2020 3,871       $ 1       123,872       (1,099) (118,903)
Beginning Balance, Shares at Dec. 31, 2020         1,484,362                  
Proceeds from the issuance of common stock       $ 8,399       $ 1       $ 8,398    
Proceeds from the issuance of common stock, Shares               744,936            
Warrant issued       $ 2,638               $ 2,638    
Share issuance costs (1,361)               (1,361)          
Proceeds from the exercise of warrants 1,318               1,318          
Proceeds from the exercise of warrants, Shares         81,895                  
Proceeds from the exercise of stock options $ 2               2          
Proceeds from the exercise of stock options, Shares 214       214                  
Settlement of restricted stock units, Shares         1,028                  
Issuance of shares as part of compensation $ 77               77          
Issuance of shares as part of compensation, Shares         5,337                  
Stock-based compensation 3,079               3,079          
Foreign currency translation adjustments (313)                       (313)  
Net loss (9,343)                         (9,343)
Ending Balance at Jun. 30, 2021 8,367       $ 2       138,023       (1,412) (128,246)
Ending Balance, Shares at Jun. 30, 2021         2,317,772                  
Beginning Balance at Mar. 31, 2021 11,898       $ 2       135,388       (1,227) (122,265)
Beginning Balance, Shares at Mar. 31, 2021         2,311,868                  
Proceeds from the exercise of warrants 4               4          
Proceeds from the exercise of warrants, Shares         262                  
Proceeds from the exercise of stock options 2               2          
Proceeds from the exercise of stock options, Shares         214                  
Settlement of restricted stock units, Shares         91                  
Issuance of shares as part of compensation 77               77          
Issuance of shares as part of compensation, Shares         5,337                  
Stock-based compensation 2,552               2,552          
Foreign currency translation adjustments (185)                       (185)  
Net loss (5,981)                         (5,981)
Ending Balance at Jun. 30, 2021 $ 8,367       $ 2       $ 138,023       $ (1,412) $ (128,246)
Ending Balance, Shares at Jun. 30, 2021         2,317,772